01Purpose and principlesWhat the treatment does and how it fits into care.
Margin assessment estimates whether microscopic disease may remain after breast conservation. The surgeon orients the specimen, pathology inks the surfaces and reports the closest distance for invasive and in-situ components. Cavity shaves can refine the true final margin only when their orientation and relationship to the primary specimen are clear. A close anterior surface at skin and a close radial parenchymal surface do not always carry the same residual-tissue context.
Current NICE wording deliberately separates “offer” from “consider”. Tumour touching a radial inked margin leads to an offer of further surgery. A narrow but clear margin triggers a shared decision at diagnosis-specific thresholds: below 1 mm for invasive cancer, below 2 mm for pure DCIS. The decision includes radiotherapy and systemic therapy but does not assume these compensate for grossly incomplete excision. Pathology-radiology concordance remains essential when calcification defines extent.
Key points
- A margin is the relationship between tumour and the inked specimen surface, not the surgeon’s visual impression of the cavity. Orientation lets pathology identify the involved direction.
- After breast-conserving surgery, NICE says offer further surgery when invasive cancer or DCIS is on ink at a radial margin, meaning 0 mm.
- For invasive cancer with or without DCIS, consider further surgery when tumour is more than 0 mm but less than 1 mm from a radial margin.
- For pure DCIS, consider further surgery when cells are more than 0 mm but less than 2 mm from a radial margin.
- “Consider” requires individual assessment of tumour features, residual disease probability, radiotherapy, comorbidity, cosmetic cost and patient preference; it is not automatic re-excision.
- Re-excision can be directed when the specimen is reliably orientated. Repeated involved margins or diffuse disease may make completion mastectomy more proportionate.
02Indications, selection and cautionsWho may benefit, who needs urgent treatment and important alternatives.
Malignant invasive or in-situ cells touch the inked radial surface, giving a 0 mm margin and a high concern for residual disease.
Invasive cancer, with or without DCIS, lies above 0 mm but below 1 mm from a radial margin and prompts consideration of further surgery.
DCIS without invasion lies above 0 mm but below 2 mm from a radial surface, using its separate NICE consideration threshold.
A reliably oriented involved margin or residual calcification can identify which cavity wall needs further excision rather than repeating an undirected lumpectomy.
03Assessment before treatmentTests and checks that guide safe selection.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Oriented specimen histopathologyFirst step - Why
- Measure invasive and DCIS distances to each inked radial surface and identify tumour at ink.
- Interpretation and limitations
- The report should separate tumour components and surfaces. Missing orientation limits directed re-excision and requires surgeon-pathologist discussion.
- 02
Specimen radiography - Why
- Confirm removal of the mammographic target and assess calcification near a specimen edge.
- Interpretation and limitations
- Residual target calcification can signal remaining DCIS even if one sampled histological margin seems clear.
- 03
Postoperative diagnostic mammography - Why
- Assess residual calcification when preoperative disease was calcification-defined and completeness remains uncertain.
- Interpretation and limitations
- Persistent suspicious calcification needs multidisciplinary correlation and may require biopsy or further excision; early postoperative change can complicate interpretation.
- 04
Multidisciplinary margin review - Why
- Integrate pathology, operative orientation, imaging extent, adjuvant therapy and cosmetic consequences.
- Interpretation and limitations
- The final action must match the diagnosis-specific threshold and patient context rather than a single distance quoted without anatomy.
04Treatment approachPreparation, options, escalation and aftercare.
01Worked case: involved marginTurn a 0 mm result into a directed planFirst stepAfter conservation for a 19 mm invasive cancer, pathology reports invasive tumour on the medial radial ink and the specimen is clearly orientated.+
- 1In this illustrative case, the pathologist confirms that the medial radial surface contains invasive tumour at ink, not merely a close margin. There is no separately submitted clear cavity shave that would change the final margin. The oriented specimen and preoperative images localise the residual concern to the medial cavity.
- 2The surgeon explains that NICE recommends offering further surgery for invasive cancer or DCIS at a 0 mm radial margin, so this invasive on-ink result requires that offer. Imaging shows a focal remaining concern and adequate breast tissue for another directed excision. The patient compares re-excision with completion mastectomy, including cosmetic cost, possible further surgery and the adjuvant-treatment plan, and chooses medial re-excision.
- 3The directed operation is completed and the new medial specimen is orientated. Pathology finds a small residual focus with a new clear radial margin; the team reconciles the original and additional specimens to establish the true final clearance rather than relying on the appearance of the cavity.
- 4At review the wound is healing and the patient understands the revised pathology. The multidisciplinary team records that the local margin question is resolved and finalises radiotherapy and systemic assessment. No further breast operation is planned on the findings of this example.
- 5The discharge and oncology letters preserve which surface was involved, what was removed and the final margin. This verifies that the offer of further surgery produced an actual assessed result; neither planned radiotherapy nor an unverified verbal assurance was used as a substitute for addressing tumour on ink.
02Close invasive pathwayApply the 1 mm consideration thresholdInvasive carcinoma with adjacent DCIS is 0.6 mm from a radial margin, with no tumour on ink.+
- 1Confirm the distance, the component closest to ink and whether the surface is radial with remaining breast tissue beyond it.
- 2Explain that NICE says consider, rather than automatically offer, further surgery for invasive disease above 0 and below 1 mm.
- 3Balance focality, residual calcification, grade, radiotherapy, further tissue volume, comorbidity and patient preference.
- 4Record either a directed re-excision plan or the reasons further surgery is not proportionate, and verify the adjuvant plan reflects that choice.
03Close pure-DCIS pathwayUse the separate 2 mm thresholdPure DCIS is 1.4 mm from the inferior radial margin after an otherwise complete excision.+
- 1Verify no invasive component and no cells on ink, because either finding changes the pathway.
- 2Consider further surgery under the pure-DCIS greater-than-0-to-less-than-2-mm recommendation.
- 3Discuss recurrence reduction, radiotherapy, likely residual burden, breast appearance and the patient’s tolerance for another operation.
- 4Check for residual calcification if imaging suggested more extensive disease, then document the agreed local-control plan.
05Complications, monitoring and follow-upAdverse effects, response and longer-term review.
- Before leaving theatre, record specimen orientation and any separately submitted cavity shaves so pathology can map findings back to the breast.
- At the postoperative meeting, track invasive and DCIS margin distances separately, including which radial surface is closest or involved.
- After re-excision, confirm whether residual disease was found and whether the new final margin is acceptable before radiotherapy begins.
- Follow wound healing, cosmetic impact and treatment delay; persistent seroma or infection needs management while the cancer timeline remains visible.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Ink defines involvement
A small measured distance is close; malignant cells touching the coloured specimen surface make the margin involved at 0 mm.
Diagnosis changes the threshold
The consideration boundary is below 1 mm for invasive cancer and below 2 mm for pure DCIS under current NICE guidance.
Orientation makes re-excision precise
Reliable sutures, clips and pathology mapping allow removal of the relevant cavity wall while preserving uninvolved breast tissue.
Cosmesis belongs in the decision
A technically possible third excision may leave a poor result; completion mastectomy with reconstructive discussion can be more proportionate.
07Common pitfallsFrequent interpretation and management errors.
- 01
Calling a 0.5 mm margin “involved” blurs the crucial distinction between tumour on ink and close but clear disease.
- 02
Applying the 2 mm pure-DCIS threshold to invasive cancer misstates the current NICE diagnosis-specific recommendation.
- 03
Recommending automatic re-excision for every close margin ignores the deliberate “consider” wording and individual risk–benefit balance.
- 04
Beginning radiotherapy while an involved margin remains unresolved can compromise the planned sequence and future surgery.